Covid-19 Impact on Global Joint Pain Injections Market Insights, Forecast to 2026
![](/report_cover/6975/covid-19-impact-on-global-joint-pain-injections-market-insights-forecast-to-2026_en.gif)
Based on injection type, the global joint pain injections market has been segmented into corticosteroid injections, hyaluronic acid injections, and others. In terms of joint type, the global joint pain injections market has been divided into knee & ankle, hip joint, shoulder & elbow, facet joints of the spine, and others. Based on distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Joint Pain Injections market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Joint Pain Injections industry.
Based on our recent survey, we have several different scenarios about the Joint Pain Injections YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2708 million in 2019. The market size of Joint Pain Injections will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Joint Pain Injections market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Joint Pain Injections market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Joint Pain Injections market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Joint Pain Injections market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Joint Pain Injections market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Joint Pain Injections market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Joint Pain Injections market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Joint Pain Injections market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Joint Pain Injections market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Joint Pain Injections industry.
Based on our recent survey, we have several different scenarios about the Joint Pain Injections YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2708 million in 2019. The market size of Joint Pain Injections will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Joint Pain Injections market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Joint Pain Injections market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Joint Pain Injections market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Joint Pain Injections market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Joint Pain Injections market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Joint Pain Injections market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Joint Pain Injections market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Joint Pain Injections market.
The following manufacturers are covered in this report:
- Allergan
- Pfizer
- Sanofi
- Anika Therapeutics
- Ferring
- Bioventus
- Flexion Therapeutics
- Zimmer Biomet Holdings
- SEIKAGAKU CORPORATION
- Chugai Pharmaceutical
- Corticosteroid Injections
- Hyaluronic Acid Injections
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
1 STUDY COVERAGE
1.1 Joint Pain Injections Product Introduction
1.2 Market Segments
1.3 Key Joint Pain Injections Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Joint Pain Injections Market Size Growth Rate by Type
1.4.2 Corticosteroid Injections
1.4.3 Hyaluronic Acid Injections
1.4.4 Others
1.5 Market by Application
1.5.1 Global Joint Pain Injections Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Joint Pain Injections Industry Impact
1.6.1 How the Covid-19 is Affecting the Joint Pain Injections Industry
1.6.1.1 Joint Pain Injections Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Joint Pain Injections Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Joint Pain Injections Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Joint Pain Injections Market Size Estimates and Forecasts
2.1.1 Global Joint Pain Injections Revenue 2015-2026
2.1.2 Global Joint Pain Injections Sales 2015-2026
2.2 Joint Pain Injections Market Size by Region: 2020 Versus 2026
2.2.1 Global Joint Pain Injections Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Joint Pain Injections Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL JOINT PAIN INJECTIONS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Joint Pain Injections Sales by Manufacturers
3.1.1 Joint Pain Injections Sales by Manufacturers (2015-2020)
3.1.2 Joint Pain Injections Sales Market Share by Manufacturers (2015-2020)
3.2 Joint Pain Injections Revenue by Manufacturers
3.2.1 Joint Pain Injections Revenue by Manufacturers (2015-2020)
3.2.2 Joint Pain Injections Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Joint Pain Injections Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Joint Pain Injections Revenue in 2019
3.2.5 Global Joint Pain Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Joint Pain Injections Price by Manufacturers
3.4 Joint Pain Injections Manufacturing Base Distribution, Product Types
3.4.1 Joint Pain Injections Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Joint Pain Injections Product Type
3.4.3 Date of International Manufacturers Enter into Joint Pain Injections Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Joint Pain Injections Market Size by Type (2015-2020)
4.1.1 Global Joint Pain Injections Sales by Type (2015-2020)
4.1.2 Global Joint Pain Injections Revenue by Type (2015-2020)
4.1.3 Joint Pain Injections Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Joint Pain Injections Market Size Forecast by Type (2021-2026)
4.2.1 Global Joint Pain Injections Sales Forecast by Type (2021-2026)
4.2.2 Global Joint Pain Injections Revenue Forecast by Type (2021-2026)
4.2.3 Joint Pain Injections Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Joint Pain Injections Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Joint Pain Injections Market Size by Application (2015-2020)
5.1.1 Global Joint Pain Injections Sales by Application (2015-2020)
5.1.2 Global Joint Pain Injections Revenue by Application (2015-2020)
5.1.3 Joint Pain Injections Price by Application (2015-2020)
5.2 Joint Pain Injections Market Size Forecast by Application (2021-2026)
5.2.1 Global Joint Pain Injections Sales Forecast by Application (2021-2026)
5.2.2 Global Joint Pain Injections Revenue Forecast by Application (2021-2026)
5.2.3 Global Joint Pain Injections Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Joint Pain Injections by Country
6.1.1 North America Joint Pain Injections Sales by Country
6.1.2 North America Joint Pain Injections Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Joint Pain Injections Market Facts & Figures by Type
6.3 North America Joint Pain Injections Market Facts & Figures by Application
7 EUROPE
7.1 Europe Joint Pain Injections by Country
7.1.1 Europe Joint Pain Injections Sales by Country
7.1.2 Europe Joint Pain Injections Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Joint Pain Injections Market Facts & Figures by Type
7.3 Europe Joint Pain Injections Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Joint Pain Injections by Region
8.1.1 Asia Pacific Joint Pain Injections Sales by Region
8.1.2 Asia Pacific Joint Pain Injections Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Joint Pain Injections Market Facts & Figures by Type
8.3 Asia Pacific Joint Pain Injections Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Joint Pain Injections by Country
9.1.1 Latin America Joint Pain Injections Sales by Country
9.1.2 Latin America Joint Pain Injections Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Joint Pain Injections Market Facts & Figures by Type
9.3 Central & South America Joint Pain Injections Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Joint Pain Injections by Country
10.1.1 Middle East and Africa Joint Pain Injections Sales by Country
10.1.2 Middle East and Africa Joint Pain Injections Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Joint Pain Injections Market Facts & Figures by Type
10.3 Middle East and Africa Joint Pain Injections Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description, Business Overview and Total Revenue
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Joint Pain Injections Products Offered
11.1.5 Allergan Recent Development
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description, Business Overview and Total Revenue
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Joint Pain Injections Products Offered
11.2.5 Pfizer Recent Development
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description, Business Overview and Total Revenue
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Joint Pain Injections Products Offered
11.3.5 Sanofi Recent Development
11.4 Anika Therapeutics
11.4.1 Anika Therapeutics Corporation Information
11.4.2 Anika Therapeutics Description, Business Overview and Total Revenue
11.4.3 Anika Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Anika Therapeutics Joint Pain Injections Products Offered
11.4.5 Anika Therapeutics Recent Development
11.5 Ferring
11.5.1 Ferring Corporation Information
11.5.2 Ferring Description, Business Overview and Total Revenue
11.5.3 Ferring Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Ferring Joint Pain Injections Products Offered
11.5.5 Ferring Recent Development
11.6 Bioventus
11.6.1 Bioventus Corporation Information
11.6.2 Bioventus Description, Business Overview and Total Revenue
11.6.3 Bioventus Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bioventus Joint Pain Injections Products Offered
11.6.5 Bioventus Recent Development
11.7 Flexion Therapeutics
11.7.1 Flexion Therapeutics Corporation Information
11.7.2 Flexion Therapeutics Description, Business Overview and Total Revenue
11.7.3 Flexion Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Flexion Therapeutics Joint Pain Injections Products Offered
11.7.5 Flexion Therapeutics Recent Development
11.8 Zimmer Biomet Holdings
11.8.1 Zimmer Biomet Holdings Corporation Information
11.8.2 Zimmer Biomet Holdings Description, Business Overview and Total Revenue
11.8.3 Zimmer Biomet Holdings Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Zimmer Biomet Holdings Joint Pain Injections Products Offered
11.8.5 Zimmer Biomet Holdings Recent Development
11.9 SEIKAGAKU CORPORATION
11.9.1 SEIKAGAKU CORPORATION Corporation Information
11.9.2 SEIKAGAKU CORPORATION Description, Business Overview and Total Revenue
11.9.3 SEIKAGAKU CORPORATION Sales, Revenue and Gross Margin (2015-2020)
11.9.4 SEIKAGAKU CORPORATION Joint Pain Injections Products Offered
11.9.5 SEIKAGAKU CORPORATION Recent Development
11.10 Chugai Pharmaceutical
11.10.1 Chugai Pharmaceutical Corporation Information
11.10.2 Chugai Pharmaceutical Description, Business Overview and Total Revenue
11.10.3 Chugai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Chugai Pharmaceutical Joint Pain Injections Products Offered
11.10.5 Chugai Pharmaceutical Recent Development
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description, Business Overview and Total Revenue
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Joint Pain Injections Products Offered
11.1.5 Allergan Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Joint Pain Injections Market Estimates and Projections by Region
12.1.1 Global Joint Pain Injections Sales Forecast by Regions 2021-2026
12.1.2 Global Joint Pain Injections Revenue Forecast by Regions 2021-2026
12.2 North America Joint Pain Injections Market Size Forecast (2021-2026)
12.2.1 North America: Joint Pain Injections Sales Forecast (2021-2026)
12.2.2 North America: Joint Pain Injections Revenue Forecast (2021-2026)
12.2.3 North America: Joint Pain Injections Market Size Forecast by Country (2021-2026)
12.3 Europe Joint Pain Injections Market Size Forecast (2021-2026)
12.3.1 Europe: Joint Pain Injections Sales Forecast (2021-2026)
12.3.2 Europe: Joint Pain Injections Revenue Forecast (2021-2026)
12.3.3 Europe: Joint Pain Injections Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Joint Pain Injections Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Joint Pain Injections Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Joint Pain Injections Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Joint Pain Injections Market Size Forecast by Region (2021-2026)
12.5 Latin America Joint Pain Injections Market Size Forecast (2021-2026)
12.5.1 Latin America: Joint Pain Injections Sales Forecast (2021-2026)
12.5.2 Latin America: Joint Pain Injections Revenue Forecast (2021-2026)
12.5.3 Latin America: Joint Pain Injections Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Joint Pain Injections Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Joint Pain Injections Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Joint Pain Injections Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Joint Pain Injections Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Joint Pain Injections Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Joint Pain Injections Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Joint Pain Injections Product Introduction
1.2 Market Segments
1.3 Key Joint Pain Injections Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Joint Pain Injections Market Size Growth Rate by Type
1.4.2 Corticosteroid Injections
1.4.3 Hyaluronic Acid Injections
1.4.4 Others
1.5 Market by Application
1.5.1 Global Joint Pain Injections Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Joint Pain Injections Industry Impact
1.6.1 How the Covid-19 is Affecting the Joint Pain Injections Industry
1.6.1.1 Joint Pain Injections Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Joint Pain Injections Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Joint Pain Injections Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Joint Pain Injections Market Size Estimates and Forecasts
2.1.1 Global Joint Pain Injections Revenue 2015-2026
2.1.2 Global Joint Pain Injections Sales 2015-2026
2.2 Joint Pain Injections Market Size by Region: 2020 Versus 2026
2.2.1 Global Joint Pain Injections Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Joint Pain Injections Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL JOINT PAIN INJECTIONS COMPETITOR LANDSCAPE BY PLAYERS
3.1 Joint Pain Injections Sales by Manufacturers
3.1.1 Joint Pain Injections Sales by Manufacturers (2015-2020)
3.1.2 Joint Pain Injections Sales Market Share by Manufacturers (2015-2020)
3.2 Joint Pain Injections Revenue by Manufacturers
3.2.1 Joint Pain Injections Revenue by Manufacturers (2015-2020)
3.2.2 Joint Pain Injections Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Joint Pain Injections Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Joint Pain Injections Revenue in 2019
3.2.5 Global Joint Pain Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Joint Pain Injections Price by Manufacturers
3.4 Joint Pain Injections Manufacturing Base Distribution, Product Types
3.4.1 Joint Pain Injections Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Joint Pain Injections Product Type
3.4.3 Date of International Manufacturers Enter into Joint Pain Injections Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Joint Pain Injections Market Size by Type (2015-2020)
4.1.1 Global Joint Pain Injections Sales by Type (2015-2020)
4.1.2 Global Joint Pain Injections Revenue by Type (2015-2020)
4.1.3 Joint Pain Injections Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Joint Pain Injections Market Size Forecast by Type (2021-2026)
4.2.1 Global Joint Pain Injections Sales Forecast by Type (2021-2026)
4.2.2 Global Joint Pain Injections Revenue Forecast by Type (2021-2026)
4.2.3 Joint Pain Injections Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Joint Pain Injections Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Joint Pain Injections Market Size by Application (2015-2020)
5.1.1 Global Joint Pain Injections Sales by Application (2015-2020)
5.1.2 Global Joint Pain Injections Revenue by Application (2015-2020)
5.1.3 Joint Pain Injections Price by Application (2015-2020)
5.2 Joint Pain Injections Market Size Forecast by Application (2021-2026)
5.2.1 Global Joint Pain Injections Sales Forecast by Application (2021-2026)
5.2.2 Global Joint Pain Injections Revenue Forecast by Application (2021-2026)
5.2.3 Global Joint Pain Injections Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Joint Pain Injections by Country
6.1.1 North America Joint Pain Injections Sales by Country
6.1.2 North America Joint Pain Injections Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Joint Pain Injections Market Facts & Figures by Type
6.3 North America Joint Pain Injections Market Facts & Figures by Application
7 EUROPE
7.1 Europe Joint Pain Injections by Country
7.1.1 Europe Joint Pain Injections Sales by Country
7.1.2 Europe Joint Pain Injections Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Joint Pain Injections Market Facts & Figures by Type
7.3 Europe Joint Pain Injections Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Joint Pain Injections by Region
8.1.1 Asia Pacific Joint Pain Injections Sales by Region
8.1.2 Asia Pacific Joint Pain Injections Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Joint Pain Injections Market Facts & Figures by Type
8.3 Asia Pacific Joint Pain Injections Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Joint Pain Injections by Country
9.1.1 Latin America Joint Pain Injections Sales by Country
9.1.2 Latin America Joint Pain Injections Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Joint Pain Injections Market Facts & Figures by Type
9.3 Central & South America Joint Pain Injections Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Joint Pain Injections by Country
10.1.1 Middle East and Africa Joint Pain Injections Sales by Country
10.1.2 Middle East and Africa Joint Pain Injections Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Joint Pain Injections Market Facts & Figures by Type
10.3 Middle East and Africa Joint Pain Injections Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description, Business Overview and Total Revenue
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Joint Pain Injections Products Offered
11.1.5 Allergan Recent Development
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description, Business Overview and Total Revenue
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Joint Pain Injections Products Offered
11.2.5 Pfizer Recent Development
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description, Business Overview and Total Revenue
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Joint Pain Injections Products Offered
11.3.5 Sanofi Recent Development
11.4 Anika Therapeutics
11.4.1 Anika Therapeutics Corporation Information
11.4.2 Anika Therapeutics Description, Business Overview and Total Revenue
11.4.3 Anika Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Anika Therapeutics Joint Pain Injections Products Offered
11.4.5 Anika Therapeutics Recent Development
11.5 Ferring
11.5.1 Ferring Corporation Information
11.5.2 Ferring Description, Business Overview and Total Revenue
11.5.3 Ferring Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Ferring Joint Pain Injections Products Offered
11.5.5 Ferring Recent Development
11.6 Bioventus
11.6.1 Bioventus Corporation Information
11.6.2 Bioventus Description, Business Overview and Total Revenue
11.6.3 Bioventus Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bioventus Joint Pain Injections Products Offered
11.6.5 Bioventus Recent Development
11.7 Flexion Therapeutics
11.7.1 Flexion Therapeutics Corporation Information
11.7.2 Flexion Therapeutics Description, Business Overview and Total Revenue
11.7.3 Flexion Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Flexion Therapeutics Joint Pain Injections Products Offered
11.7.5 Flexion Therapeutics Recent Development
11.8 Zimmer Biomet Holdings
11.8.1 Zimmer Biomet Holdings Corporation Information
11.8.2 Zimmer Biomet Holdings Description, Business Overview and Total Revenue
11.8.3 Zimmer Biomet Holdings Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Zimmer Biomet Holdings Joint Pain Injections Products Offered
11.8.5 Zimmer Biomet Holdings Recent Development
11.9 SEIKAGAKU CORPORATION
11.9.1 SEIKAGAKU CORPORATION Corporation Information
11.9.2 SEIKAGAKU CORPORATION Description, Business Overview and Total Revenue
11.9.3 SEIKAGAKU CORPORATION Sales, Revenue and Gross Margin (2015-2020)
11.9.4 SEIKAGAKU CORPORATION Joint Pain Injections Products Offered
11.9.5 SEIKAGAKU CORPORATION Recent Development
11.10 Chugai Pharmaceutical
11.10.1 Chugai Pharmaceutical Corporation Information
11.10.2 Chugai Pharmaceutical Description, Business Overview and Total Revenue
11.10.3 Chugai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Chugai Pharmaceutical Joint Pain Injections Products Offered
11.10.5 Chugai Pharmaceutical Recent Development
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description, Business Overview and Total Revenue
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Joint Pain Injections Products Offered
11.1.5 Allergan Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Joint Pain Injections Market Estimates and Projections by Region
12.1.1 Global Joint Pain Injections Sales Forecast by Regions 2021-2026
12.1.2 Global Joint Pain Injections Revenue Forecast by Regions 2021-2026
12.2 North America Joint Pain Injections Market Size Forecast (2021-2026)
12.2.1 North America: Joint Pain Injections Sales Forecast (2021-2026)
12.2.2 North America: Joint Pain Injections Revenue Forecast (2021-2026)
12.2.3 North America: Joint Pain Injections Market Size Forecast by Country (2021-2026)
12.3 Europe Joint Pain Injections Market Size Forecast (2021-2026)
12.3.1 Europe: Joint Pain Injections Sales Forecast (2021-2026)
12.3.2 Europe: Joint Pain Injections Revenue Forecast (2021-2026)
12.3.3 Europe: Joint Pain Injections Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Joint Pain Injections Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Joint Pain Injections Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Joint Pain Injections Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Joint Pain Injections Market Size Forecast by Region (2021-2026)
12.5 Latin America Joint Pain Injections Market Size Forecast (2021-2026)
12.5.1 Latin America: Joint Pain Injections Sales Forecast (2021-2026)
12.5.2 Latin America: Joint Pain Injections Revenue Forecast (2021-2026)
12.5.3 Latin America: Joint Pain Injections Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Joint Pain Injections Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Joint Pain Injections Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Joint Pain Injections Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Joint Pain Injections Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Joint Pain Injections Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Joint Pain Injections Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Joint Pain Injections Market Segments
Table 2. Ranking of Global Top Joint Pain Injections Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Joint Pain Injections Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Corticosteroid Injections
Table 5. Major Manufacturers of Hyaluronic Acid Injections
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Joint Pain Injections Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Joint Pain Injections Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Joint Pain Injections Players to Combat Covid-19 Impact
Table 12. Global Joint Pain Injections Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Joint Pain Injections Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Joint Pain Injections Sales by Regions 2015-2020 (K Units)
Table 15. Global Joint Pain Injections Sales Market Share by Regions (2015-2020)
Table 16. Global Joint Pain Injections Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Joint Pain Injections Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Joint Pain Injections Sales Share by Manufacturers (2015-2020)
Table 19. Global Joint Pain Injections Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Joint Pain Injections by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Joint Pain Injections as of 2019)
Table 21. Joint Pain Injections Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Joint Pain Injections Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Joint Pain Injections Price (2015-2020) (USD/Unit)
Table 24. Joint Pain Injections Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Joint Pain Injections Product Type
Table 26. Date of International Manufacturers Enter into Joint Pain Injections Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Joint Pain Injections Sales by Type (2015-2020) (K Units)
Table 29. Global Joint Pain Injections Sales Share by Type (2015-2020)
Table 30. Global Joint Pain Injections Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Joint Pain Injections Revenue Share by Type (2015-2020)
Table 32. Joint Pain Injections Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Joint Pain Injections Sales by Application (2015-2020) (K Units)
Table 34. Global Joint Pain Injections Sales Share by Application (2015-2020)
Table 35. North America Joint Pain Injections Sales by Country (2015-2020) (K Units)
Table 36. North America Joint Pain Injections Sales Market Share by Country (2015-2020)
Table 37. North America Joint Pain Injections Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Joint Pain Injections Revenue Market Share by Country (2015-2020)
Table 39. North America Joint Pain Injections Sales by Type (2015-2020) (K Units)
Table 40. North America Joint Pain Injections Sales Market Share by Type (2015-2020)
Table 41. North America Joint Pain Injections Sales by Application (2015-2020) (K Units)
Table 42. North America Joint Pain Injections Sales Market Share by Application (2015-2020)
Table 43. Europe Joint Pain Injections Sales by Country (2015-2020) (K Units)
Table 44. Europe Joint Pain Injections Sales Market Share by Country (2015-2020)
Table 45. Europe Joint Pain Injections Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Joint Pain Injections Revenue Market Share by Country (2015-2020)
Table 47. Europe Joint Pain Injections Sales by Type (2015-2020) (K Units)
Table 48. Europe Joint Pain Injections Sales Market Share by Type (2015-2020)
Table 49. Europe Joint Pain Injections Sales by Application (2015-2020) (K Units)
Table 50. Europe Joint Pain Injections Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Joint Pain Injections Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Joint Pain Injections Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Joint Pain Injections Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Joint Pain Injections Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Joint Pain Injections Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Joint Pain Injections Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Joint Pain Injections Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Joint Pain Injections Sales Market Share by Application (2015-2020)
Table 59. Latin America Joint Pain Injections Sales by Country (2015-2020) (K Units)
Table 60. Latin America Joint Pain Injections Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Joint Pain Injections Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Joint Pain Injections Revenue Market Share by Country (2015-2020)
Table 63. Latin America Joint Pain Injections Sales by Type (2015-2020) (K Units)
Table 64. Latin America Joint Pain Injections Sales Market Share by Type (2015-2020)
Table 65. Latin America Joint Pain Injections Sales by Application (2015-2020) (K Units)
Table 66. Latin America Joint Pain Injections Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Joint Pain Injections Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Joint Pain Injections Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Joint Pain Injections Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Joint Pain Injections Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Joint Pain Injections Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Joint Pain Injections Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Joint Pain Injections Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Joint Pain Injections Sales Market Share by Application (2015-2020)
Table 75. Allergan Corporation Information
Table 76. Allergan Description and Major Businesses
Table 77. Allergan Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Allergan Product
Table 79. Allergan Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Major Businesses
Table 82. Pfizer Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pfizer Product
Table 84. Pfizer Recent Development
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Major Businesses
Table 87. Sanofi Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Sanofi Product
Table 89. Sanofi Recent Development
Table 90. Anika Therapeutics Corporation Information
Table 91. Anika Therapeutics Description and Major Businesses
Table 92. Anika Therapeutics Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Anika Therapeutics Product
Table 94. Anika Therapeutics Recent Development
Table 95. Ferring Corporation Information
Table 96. Ferring Description and Major Businesses
Table 97. Ferring Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Ferring Product
Table 99. Ferring Recent Development
Table 100. Bioventus Corporation Information
Table 101. Bioventus Description and Major Businesses
Table 102. Bioventus Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Bioventus Product
Table 104. Bioventus Recent Development
Table 105. Flexion Therapeutics Corporation Information
Table 106. Flexion Therapeutics Description and Major Businesses
Table 107. Flexion Therapeutics Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Flexion Therapeutics Product
Table 109. Flexion Therapeutics Recent Development
Table 110. Zimmer Biomet Holdings Corporation Information
Table 111. Zimmer Biomet Holdings Description and Major Businesses
Table 112. Zimmer Biomet Holdings Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Zimmer Biomet Holdings Product
Table 114. Zimmer Biomet Holdings Recent Development
Table 115. SEIKAGAKU CORPORATION Corporation Information
Table 116. SEIKAGAKU CORPORATION Description and Major Businesses
Table 117. SEIKAGAKU CORPORATION Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. SEIKAGAKU CORPORATION Product
Table 119. SEIKAGAKU CORPORATION Recent Development
Table 120. Chugai Pharmaceutical Corporation Information
Table 121. Chugai Pharmaceutical Description and Major Businesses
Table 122. Chugai Pharmaceutical Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Chugai Pharmaceutical Product
Table 124. Chugai Pharmaceutical Recent Development
Table 125. Global Joint Pain Injections Sales Forecast by Regions (2021-2026) (K Units)
Table 126. Global Joint Pain Injections Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Joint Pain Injections Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Joint Pain Injections Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Joint Pain Injections Sales Forecast by Country (2021-2026) (K Units)
Table 130. North America: Joint Pain Injections Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Joint Pain Injections Sales Forecast by Country (2021-2026) (K Units)
Table 132. Europe: Joint Pain Injections Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Joint Pain Injections Sales Forecast by Region (2021-2026) (K Units)
Table 134. Asia Pacific: Joint Pain Injections Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Joint Pain Injections Sales Forecast by Country (2021-2026) (K Units)
Table 136. Latin America: Joint Pain Injections Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Joint Pain Injections Sales Forecast by Country (2021-2026) (K Units)
Table 138. Middle East and Africa: Joint Pain Injections Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Joint Pain Injections Players
Table 143. Joint Pain Injections Customers List
Table 144. Joint Pain Injections Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 1. Joint Pain Injections Market Segments
Table 2. Ranking of Global Top Joint Pain Injections Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Joint Pain Injections Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Corticosteroid Injections
Table 5. Major Manufacturers of Hyaluronic Acid Injections
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Joint Pain Injections Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Joint Pain Injections Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Joint Pain Injections Players to Combat Covid-19 Impact
Table 12. Global Joint Pain Injections Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Joint Pain Injections Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Joint Pain Injections Sales by Regions 2015-2020 (K Units)
Table 15. Global Joint Pain Injections Sales Market Share by Regions (2015-2020)
Table 16. Global Joint Pain Injections Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Joint Pain Injections Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Joint Pain Injections Sales Share by Manufacturers (2015-2020)
Table 19. Global Joint Pain Injections Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Joint Pain Injections by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Joint Pain Injections as of 2019)
Table 21. Joint Pain Injections Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Joint Pain Injections Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Joint Pain Injections Price (2015-2020) (USD/Unit)
Table 24. Joint Pain Injections Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Joint Pain Injections Product Type
Table 26. Date of International Manufacturers Enter into Joint Pain Injections Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Joint Pain Injections Sales by Type (2015-2020) (K Units)
Table 29. Global Joint Pain Injections Sales Share by Type (2015-2020)
Table 30. Global Joint Pain Injections Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Joint Pain Injections Revenue Share by Type (2015-2020)
Table 32. Joint Pain Injections Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Joint Pain Injections Sales by Application (2015-2020) (K Units)
Table 34. Global Joint Pain Injections Sales Share by Application (2015-2020)
Table 35. North America Joint Pain Injections Sales by Country (2015-2020) (K Units)
Table 36. North America Joint Pain Injections Sales Market Share by Country (2015-2020)
Table 37. North America Joint Pain Injections Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Joint Pain Injections Revenue Market Share by Country (2015-2020)
Table 39. North America Joint Pain Injections Sales by Type (2015-2020) (K Units)
Table 40. North America Joint Pain Injections Sales Market Share by Type (2015-2020)
Table 41. North America Joint Pain Injections Sales by Application (2015-2020) (K Units)
Table 42. North America Joint Pain Injections Sales Market Share by Application (2015-2020)
Table 43. Europe Joint Pain Injections Sales by Country (2015-2020) (K Units)
Table 44. Europe Joint Pain Injections Sales Market Share by Country (2015-2020)
Table 45. Europe Joint Pain Injections Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Joint Pain Injections Revenue Market Share by Country (2015-2020)
Table 47. Europe Joint Pain Injections Sales by Type (2015-2020) (K Units)
Table 48. Europe Joint Pain Injections Sales Market Share by Type (2015-2020)
Table 49. Europe Joint Pain Injections Sales by Application (2015-2020) (K Units)
Table 50. Europe Joint Pain Injections Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Joint Pain Injections Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Joint Pain Injections Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Joint Pain Injections Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Joint Pain Injections Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Joint Pain Injections Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Joint Pain Injections Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Joint Pain Injections Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Joint Pain Injections Sales Market Share by Application (2015-2020)
Table 59. Latin America Joint Pain Injections Sales by Country (2015-2020) (K Units)
Table 60. Latin America Joint Pain Injections Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Joint Pain Injections Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Joint Pain Injections Revenue Market Share by Country (2015-2020)
Table 63. Latin America Joint Pain Injections Sales by Type (2015-2020) (K Units)
Table 64. Latin America Joint Pain Injections Sales Market Share by Type (2015-2020)
Table 65. Latin America Joint Pain Injections Sales by Application (2015-2020) (K Units)
Table 66. Latin America Joint Pain Injections Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Joint Pain Injections Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Joint Pain Injections Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Joint Pain Injections Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Joint Pain Injections Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Joint Pain Injections Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Joint Pain Injections Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Joint Pain Injections Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Joint Pain Injections Sales Market Share by Application (2015-2020)
Table 75. Allergan Corporation Information
Table 76. Allergan Description and Major Businesses
Table 77. Allergan Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Allergan Product
Table 79. Allergan Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Major Businesses
Table 82. Pfizer Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pfizer Product
Table 84. Pfizer Recent Development
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Major Businesses
Table 87. Sanofi Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Sanofi Product
Table 89. Sanofi Recent Development
Table 90. Anika Therapeutics Corporation Information
Table 91. Anika Therapeutics Description and Major Businesses
Table 92. Anika Therapeutics Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Anika Therapeutics Product
Table 94. Anika Therapeutics Recent Development
Table 95. Ferring Corporation Information
Table 96. Ferring Description and Major Businesses
Table 97. Ferring Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Ferring Product
Table 99. Ferring Recent Development
Table 100. Bioventus Corporation Information
Table 101. Bioventus Description and Major Businesses
Table 102. Bioventus Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Bioventus Product
Table 104. Bioventus Recent Development
Table 105. Flexion Therapeutics Corporation Information
Table 106. Flexion Therapeutics Description and Major Businesses
Table 107. Flexion Therapeutics Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Flexion Therapeutics Product
Table 109. Flexion Therapeutics Recent Development
Table 110. Zimmer Biomet Holdings Corporation Information
Table 111. Zimmer Biomet Holdings Description and Major Businesses
Table 112. Zimmer Biomet Holdings Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Zimmer Biomet Holdings Product
Table 114. Zimmer Biomet Holdings Recent Development
Table 115. SEIKAGAKU CORPORATION Corporation Information
Table 116. SEIKAGAKU CORPORATION Description and Major Businesses
Table 117. SEIKAGAKU CORPORATION Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. SEIKAGAKU CORPORATION Product
Table 119. SEIKAGAKU CORPORATION Recent Development
Table 120. Chugai Pharmaceutical Corporation Information
Table 121. Chugai Pharmaceutical Description and Major Businesses
Table 122. Chugai Pharmaceutical Joint Pain Injections Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Chugai Pharmaceutical Product
Table 124. Chugai Pharmaceutical Recent Development
Table 125. Global Joint Pain Injections Sales Forecast by Regions (2021-2026) (K Units)
Table 126. Global Joint Pain Injections Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Joint Pain Injections Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Joint Pain Injections Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Joint Pain Injections Sales Forecast by Country (2021-2026) (K Units)
Table 130. North America: Joint Pain Injections Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Joint Pain Injections Sales Forecast by Country (2021-2026) (K Units)
Table 132. Europe: Joint Pain Injections Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Joint Pain Injections Sales Forecast by Region (2021-2026) (K Units)
Table 134. Asia Pacific: Joint Pain Injections Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Joint Pain Injections Sales Forecast by Country (2021-2026) (K Units)
Table 136. Latin America: Joint Pain Injections Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Joint Pain Injections Sales Forecast by Country (2021-2026) (K Units)
Table 138. Middle East and Africa: Joint Pain Injections Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Joint Pain Injections Players
Table 143. Joint Pain Injections Customers List
Table 144. Joint Pain Injections Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Joint Pain Injections Product Picture
Figure 2. Global Joint Pain Injections Sales Market Share by Type in 2020 & 2026
Figure 3. Corticosteroid Injections Product Picture
Figure 4. Hyaluronic Acid Injections Product Picture
Figure 5. Others Product Picture
Figure 6. Global Joint Pain Injections Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Joint Pain Injections Report Years Considered
Figure 11. Global Joint Pain Injections Market Size 2015-2026 (US$ Million)
Figure 12. Global Joint Pain Injections Sales 2015-2026 (K Units)
Figure 13. Global Joint Pain Injections Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Joint Pain Injections Sales Market Share by Region (2015-2020)
Figure 15. Global Joint Pain Injections Sales Market Share by Region in 2019
Figure 16. Global Joint Pain Injections Revenue Market Share by Region (2015-2020)
Figure 17. Global Joint Pain Injections Revenue Market Share by Region in 2019
Figure 18. Global Joint Pain Injections Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Joint Pain Injections Revenue in 2019
Figure 20. Joint Pain Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Joint Pain Injections Sales Market Share by Type (2015-2020)
Figure 22. Global Joint Pain Injections Sales Market Share by Type in 2019
Figure 23. Global Joint Pain Injections Revenue Market Share by Type (2015-2020)
Figure 24. Global Joint Pain Injections Revenue Market Share by Type in 2019
Figure 25. Global Joint Pain Injections Market Share by Price Range (2015-2020)
Figure 26. Global Joint Pain Injections Sales Market Share by Application (2015-2020)
Figure 27. Global Joint Pain Injections Sales Market Share by Application in 2019
Figure 28. Global Joint Pain Injections Revenue Market Share by Application (2015-2020)
Figure 29. Global Joint Pain Injections Revenue Market Share by Application in 2019
Figure 30. North America Joint Pain Injections Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Joint Pain Injections Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Joint Pain Injections Sales Market Share by Country in 2019
Figure 33. North America Joint Pain Injections Revenue Market Share by Country in 2019
Figure 34. U.S. Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Joint Pain Injections Market Share by Type in 2019
Figure 39. North America Joint Pain Injections Market Share by Application in 2019
Figure 40. Europe Joint Pain Injections Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Joint Pain Injections Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Joint Pain Injections Sales Market Share by Country in 2019
Figure 43. Europe Joint Pain Injections Revenue Market Share by Country in 2019
Figure 44. Germany Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Joint Pain Injections Market Share by Type in 2019
Figure 55. Europe Joint Pain Injections Market Share by Application in 2019
Figure 56. Asia Pacific Joint Pain Injections Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Joint Pain Injections Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Joint Pain Injections Sales Market Share by Region in 2019
Figure 59. Asia Pacific Joint Pain Injections Revenue Market Share by Region in 2019
Figure 60. China Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Joint Pain Injections Market Share by Type in 2019
Figure 83. Asia Pacific Joint Pain Injections Market Share by Application in 2019
Figure 84. Latin America Joint Pain Injections Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Joint Pain Injections Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Joint Pain Injections Sales Market Share by Country in 2019
Figure 87. Latin America Joint Pain Injections Revenue Market Share by Country in 2019
Figure 88. Mexico Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Joint Pain Injections Market Share by Type in 2019
Figure 95. Latin America Joint Pain Injections Market Share by Application in 2019
Figure 96. Middle East and Africa Joint Pain Injections Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Joint Pain Injections Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Joint Pain Injections Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Joint Pain Injections Revenue Market Share by Country in 2019
Figure 100. Turkey Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Joint Pain Injections Market Share by Type in 2019
Figure 107. Middle East and Africa Joint Pain Injections Market Share by Application in 2019
Figure 108. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Anika Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Ferring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bioventus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Flexion Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Zimmer Biomet Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. SEIKAGAKU CORPORATION Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Chugai Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America Joint Pain Injections Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. North America Joint Pain Injections Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Joint Pain Injections Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Europe Joint Pain Injections Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Joint Pain Injections Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Asia Pacific Joint Pain Injections Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Joint Pain Injections Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Latin America Joint Pain Injections Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Joint Pain Injections Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Middle East and Africa Joint Pain Injections Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed
Figure 1. Joint Pain Injections Product Picture
Figure 2. Global Joint Pain Injections Sales Market Share by Type in 2020 & 2026
Figure 3. Corticosteroid Injections Product Picture
Figure 4. Hyaluronic Acid Injections Product Picture
Figure 5. Others Product Picture
Figure 6. Global Joint Pain Injections Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Joint Pain Injections Report Years Considered
Figure 11. Global Joint Pain Injections Market Size 2015-2026 (US$ Million)
Figure 12. Global Joint Pain Injections Sales 2015-2026 (K Units)
Figure 13. Global Joint Pain Injections Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Joint Pain Injections Sales Market Share by Region (2015-2020)
Figure 15. Global Joint Pain Injections Sales Market Share by Region in 2019
Figure 16. Global Joint Pain Injections Revenue Market Share by Region (2015-2020)
Figure 17. Global Joint Pain Injections Revenue Market Share by Region in 2019
Figure 18. Global Joint Pain Injections Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Joint Pain Injections Revenue in 2019
Figure 20. Joint Pain Injections Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Joint Pain Injections Sales Market Share by Type (2015-2020)
Figure 22. Global Joint Pain Injections Sales Market Share by Type in 2019
Figure 23. Global Joint Pain Injections Revenue Market Share by Type (2015-2020)
Figure 24. Global Joint Pain Injections Revenue Market Share by Type in 2019
Figure 25. Global Joint Pain Injections Market Share by Price Range (2015-2020)
Figure 26. Global Joint Pain Injections Sales Market Share by Application (2015-2020)
Figure 27. Global Joint Pain Injections Sales Market Share by Application in 2019
Figure 28. Global Joint Pain Injections Revenue Market Share by Application (2015-2020)
Figure 29. Global Joint Pain Injections Revenue Market Share by Application in 2019
Figure 30. North America Joint Pain Injections Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Joint Pain Injections Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Joint Pain Injections Sales Market Share by Country in 2019
Figure 33. North America Joint Pain Injections Revenue Market Share by Country in 2019
Figure 34. U.S. Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Joint Pain Injections Market Share by Type in 2019
Figure 39. North America Joint Pain Injections Market Share by Application in 2019
Figure 40. Europe Joint Pain Injections Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Joint Pain Injections Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Joint Pain Injections Sales Market Share by Country in 2019
Figure 43. Europe Joint Pain Injections Revenue Market Share by Country in 2019
Figure 44. Germany Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Joint Pain Injections Market Share by Type in 2019
Figure 55. Europe Joint Pain Injections Market Share by Application in 2019
Figure 56. Asia Pacific Joint Pain Injections Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Joint Pain Injections Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Joint Pain Injections Sales Market Share by Region in 2019
Figure 59. Asia Pacific Joint Pain Injections Revenue Market Share by Region in 2019
Figure 60. China Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Joint Pain Injections Market Share by Type in 2019
Figure 83. Asia Pacific Joint Pain Injections Market Share by Application in 2019
Figure 84. Latin America Joint Pain Injections Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Joint Pain Injections Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Joint Pain Injections Sales Market Share by Country in 2019
Figure 87. Latin America Joint Pain Injections Revenue Market Share by Country in 2019
Figure 88. Mexico Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Joint Pain Injections Market Share by Type in 2019
Figure 95. Latin America Joint Pain Injections Market Share by Application in 2019
Figure 96. Middle East and Africa Joint Pain Injections Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Joint Pain Injections Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Joint Pain Injections Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Joint Pain Injections Revenue Market Share by Country in 2019
Figure 100. Turkey Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Joint Pain Injections Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Joint Pain Injections Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Joint Pain Injections Market Share by Type in 2019
Figure 107. Middle East and Africa Joint Pain Injections Market Share by Application in 2019
Figure 108. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Anika Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Ferring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Bioventus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Flexion Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Zimmer Biomet Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. SEIKAGAKU CORPORATION Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Chugai Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. North America Joint Pain Injections Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. North America Joint Pain Injections Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Europe Joint Pain Injections Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Europe Joint Pain Injections Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Asia Pacific Joint Pain Injections Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Asia Pacific Joint Pain Injections Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Latin America Joint Pain Injections Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 125. Latin America Joint Pain Injections Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Middle East and Africa Joint Pain Injections Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 127. Middle East and Africa Joint Pain Injections Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Porter's Five Forces Analysis
Figure 129. Channels of Distribution
Figure 130. Distributors Profiles
Figure 131. Bottom-up and Top-down Approaches for This Report
Figure 132. Data Triangulation
Figure 133. Key Executives Interviewed